CancerMA: a web-based tool for automatic meta-analysis of public cancer microarray data

Area of Science:

• Bioinformatics
• Cancer Research
• Genomics

Background:

• Identifying novel cancer markers is crucial for developing effective cancer therapies.
• Analyzing large-scale 'omic' data requires accessible and automated computational approaches.
• Managing vast datasets and narrowing down potential gene targets necessitates advanced data integration and analysis techniques.

Purpose of the Study:

• To present CancerMA, an integrated bioinformatics pipeline for automated identification of novel cancer markers and targets.
• To provide researchers with an accessible tool for analyzing gene expression profiles across multiple cancer types.
• To facilitate the discovery of new therapeutic targets by meta-analyzing publicly available cancer microarray data.

Main Methods:

• Development of CancerMA, an online, integrated bioinformatics pipeline.
• Meta-analysis of gene expression profiles from user-defined gene sets.
• Utilizing a curated database of 80 cancer microarray datasets covering 13 cancer types.
• Implementation of a user-friendly web interface for analysis initiation and results retrieval.

Main Results:

• CancerMA enables automated identification of novel candidate cancer markers/targets.
• The pipeline successfully meta-analyzes gene expression data across diverse cancer types.
• Demonstrated functionality through two validation datasets, showcasing its utility for cancer research.

Conclusions:

• CancerMA offers a powerful, automated solution for discovering novel cancer targets.
• The tool democratizes access to complex data analysis for a wider research community.
• Facilitates accelerated development of targeted cancer therapies through efficient marker identification.